Biology subjects

Tiwari, S.

Publications and source records attributed to Tiwari, S..

At least 37 records · Page 2Linked to original sources

bioRxiv2025

Electrostatics Govern Protein Orientation on Citrate-Capped Gold Nanoparticles

Conjugation of proteins with gold nanoparticles (GNPs) is crucial in developing nanoparticle-based drugs, which are used in making targeted delivery systems for therapeutic and diagnostic use. This conjugation is often mediated by covalent gold-thiol (Au-S) bonds involving cysteine residues. However, the influence of other interactions, like electrostatics, on protein-GNP interactions remains poorly understood. While the independent roles of cysteine (thiol interactions) and lysine (electrostatics) are studied, how these two distinct mechanisms couple and mutually influence one another remains unknown. It is particularly unclear how the position and the electrostatics around cysteine residues within the protein structure modulate their interaction with GNPs. Hence, to isolate the electrostatic contribution from Au-S interaction, we systematically investigated the role of positively charged lysine in protein interaction with citrate-capped GNPs using protein L, a cysteine-free antibody-binding protein. Protein L has seven lysine residues, positively charged at pH 7.4. Each lysine was individually mutated to cysteine to create single-cysteine variants. The capping strength of these mutants on citrate-capped GNPs was assessed using various biophysical techniques. Surprisingly, not all cysteine mutants formed stable covalent conjugates. The K7C mutant, in particular, showed strong and irreversible GNP capping, not solely due to the introduced cysteine, but also because of nearby positively charged residues that promoted electrostatic attraction to the negatively charged citrate-capped GNP surface. This critical role of electrostatics was further confirmed using lysine acrylation, which effectively capped lysines and prevented their interaction. Our experimental plan was thus able to successfully decouple the contributions of Au-S bonding from lysine-driven electrostatics. These sequential and cooperative studies underscore that electrostatic and covalent factors are not independent but part of an interconnected process, thereby underscoring the need to consider local charge environments in protein engineering for nanoparticle conjugation.

biophysics↗

bioRxiv2025

Metabolic modulation in liver by glucan from Enterococcus hirae (OL616073) via gut-liver axis culture model of steatosis

Metabolic dysfunction associated fatty liver disease (MAFLD) starts with increased fat deposition called steatosis progressing towards steatohepatitis, fibrosis, cirrhosis and end stage liver disease. Dysfunctional metabolism in type-2 diabetes or obesity is associated with gut dysbiosis, causing release of gut microbial endotoxins like lipopolysaccharides (LPS) into the liver via portal circulation also known as gut-liver axis. Endotoxins or LPS signals metabolic changes in the liver initiating steatosis via gut-liver axis. Various pre-clinical models have been studied to evaluate the role of fermented food derived bioactive compounds preventing the process of steatosis. Among them exopolysaccharides (EPS), as a part of fermented foods have been reported to produce metabolites by the gut microbial fermentation, providing liver with health benefits. In the present study, we have evaluated the role of a noble EPS or G (glucan) in the condition of liver steatosis by using cell culture model of gut-liver axis by co-culturing Caco-2 and HepG2 cells in transwell culture dishes. LPS was used to mimic gut dysbiosis, with or without pre-treatment of G to caco-2 cells in the upper chamber, wherease, HepG2 cells in lower chamber were extracted for metabolites to be analyzed by LC-Q-TOF. The global metabolomic profiles of LPS+G+ and LPS+ treated cells were compared. The primary target of G showed its role in cholesterol and primary bile acid metabolism along with changes in nucleotide, vitamins and branched chain aminoacid metabolites helpful in reducing fatty liver. Future studies with this glucan using targeted metabolomics could confirm biomarkers of therapeutic intervention of steatosis and could be translated into healthy food products.

biochemistry↗

bioRxiv2025

HM-DyadCap - Capture and Mapping of 5-Hydroxymethyl-cytosine/5-Methylcytosine CpG Dyads in Mammalian DNA

5-Methylcytosine (mC) and 5-hydroxymethylcytosine (hmC) are the main epigenetic modifications of mammalian DNA, and play crucial roles in cell differentiation, development, and tumorigenesis. Both modifications co-exist with unmodified cytosine in palindromic CpG dyads in different symmetric and asymmetric combinations across the two DNA strands, each having unique regulatory potential. To facilitate investigating the individual functions of such dyad modifications, we report HM-DyadCap. This method employs an evolved methyl-CpG-binding domain (MECP2 HM) for the direct capture and sequencing of DNA fragments containing the CpG dyad hmC/mC. Binding studies reveal a high discrimination of MECP2 HM against off-target dinucleotides. We conduct comparative mapping experiments for mESC genomes with HM-DyadCap, standard MethylCap employing wild type MECP2, as well as MeDIP and hMeDIP protocols. We find that MECP2 HM is blocked by hmC glucosylation, and conduct control enrichments with glucosylated genomes that indicate highly selective enrichment of hmC/mC dyads by MECP2 HM. Metagene profiles correlate hmC/mC marks with actively transcribed genes, and reveal global enrichment in gene bodies as well as depletion at transcription start sites. We anticipate that HM-DyadCap will enable effective enrichment and mapping of hmC/mC marks with broad applicability for unravelling the function of this dyad in chromatin biology and cancer.

genomics↗

bioRxiv2025

Rapid Liquid Chromatography-Mass Spectrometry (rLC-MS) for Deep Metabolomics Analysis of Population Scale Studies

Mass spectrometry (MS)-based metabolomics is a key technology for the interrogation of exogenous and endogenous small molecule mediators that influence human health and disease. To date, however, low throughput of MS systems have largely precluded large-scale metabolomics studies of human populations, limiting power to discover physiological roles of metabolites. Here, we introduce a fully automated rapid liquid chromatography-mass spectrometry (rLC-MS) system coupled to an AI-enabled computational pipeline that enables high-throughput, reproducible, non-targeted metabolite measurements across tens of thousands of samples. This system captures thousands of polar, amphipathic and nonpolar (lipid) metabolites in a human plasma sample in 53 seconds of analytical time, enabling analysis of greater than 1,000 samples per day per instrument. To demonstrate the discovery power of the rLC-MS platform, a subset of samples from Sapients DynamiQ biorepository - comprised of 62,039 total plasma samples collected longitudinally from 11,045 individuals - were selected for deep analysis by rLC-MS to capture a rich, dynamic landscape of chemical variation that reflects both physiological processes and environmental influences. 26,042 plasma samples with matched real-world data (RWD) were chosen for the study, representing 6,935 individuals with diverse demographic backgrounds and disease profiles. Unbiased exploratory analysis revealed human metabotypes that correlate with heterogenous disease phenotypes, including key sub-populations of cardiometabolic and other human diseases. Moreover, a metabolic aging clock machine learning model trained on healthy individuals in this dataset accurately predicted accelerated aging in various chronic diseases, with dynamic reversal of metabolic aging following definitive therapy. These data demonstrate that the rLC-MS platform enables prediction of clinically relevant physiological states from plasma metabolomics at scale in human populations.

biochemistry↗

bioRxiv2025

Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity

DNA-lipid nanoparticles (DNA-LNPs) loaded with inhibitors of the cGAS-STING pathway enable safe and effective delivery of DNA in vivo. Herein, we report the first instances of extrahepatic DNA-LNP targeting. DNA-LNPs conjugated to antibodies against PECAM-1 or VCAM-1 target the endothelium of the lungs and brain/spleen, respectively. These LNPs drive robust transgene expression in their target organs, with greater magnitude and duration than untargeted LNPs. Lung specificity of PECAM-targeted transgene expression increases over two weeks, resulting in markedly higher lung-to-liver expression ratios than our previous PECAM-targeted mRNA-LNPs. Off-target liver DNA expression declines to undetectable levels but persists in the lungs, while mRNA expression uniformly decreases due to its short half-life. We further improve this expression specificity by replacing full-length antibodies with Fab fragments. Single-cell analysis reveals a key mechanism underlying the improvements in organ-specificity: target organ expression is dominated by long-lived endothelial cells, while off-target liver delivery and expression are in non-endothelial cells with shorter half-lives. Collectively, these studies demonstrate that targeted DNA-LNPs achieve high levels of organ- and cell-type-specific transgene expression and thus provide a therapeutic platform for dozens of endothelial-centric diseases.

bioengineering↗

bioRxiv2025

Mechanism of phosphorylation dependent interactions of complete Retinoblastoma-AB pocket domain with its linker

Retinoblastoma protein (pRb) is a critical tumor suppressor, whose activity is regulated through phosphorylation of Serine/Threonine residues within unstructured linker regions. Due to the absence of high-resolution structures encompassing these linkers, many studies have indirectly examined the phosphorylation effects on pRb-protein interactions. Here, we present computational models of the full pRb pocket domain (pRbAB), incorporating the flexible linker (pRbPL) that connects boxes A and B. Three models, generated by ROBETTA and AlphaFold, were used to explore the mechanisms by which phosphorylation at Ser608 and Ser612 influence the interaction of pRbAB with E2F transactivation domain (E2FTA). All models revealed a short helix (residues 602-607), similar to that observed in a previously published crystal structure of pRbAB with shortened pRbPL linker and phosphomimetic mutation at Ser608, with E2FTA (PDB:4ELL), and proposed to competitively inhibit E2FTA binding. Interestingly, this helix formed irrespective of phosphorylation, indicating that additional factors influencing the interaction upon phosphorylation. In our models, the pRbPL linker displayed significant motion, especially near Ser608 and Ser612, facilitating phosphorylation, but without inducing large conformational changes in the pocket domains. Phosphorylation at Ser608 and Ser612 resulted in changes in multiple parameters including electrostatic properties, compactness and energy landscape of pRbAB constituting important mechanisms that promote E2F release. Additionally, recapitulating known R661W mutation in these models correctly showed reduced E2FTA binding, demonstrating the predictive power of these models to study the effects of missense mutations on the stability, conformation and interactions of pRbAB with E2FTA.

cell biology↗

bioRxiv2025

The decameric repeat (DR) of PSGL-1 functions as a basic antiviral unit in restricting HIV-1 infectivity

PSGL-1 (P-selectin glycoprotein ligand-1) is a dimeric, mucin-like surface glycoprotein that interacts with selectins on the endothelium, facilitating leukocyte tethering and rolling during transmigration. Previous studies have demonstrated that PSGL-1 acts as an HIV restriction factor, blocking HIV infectivity by hindering particle attachment to target cells. A large part of PSGL-1s extracellular region consists of a mucin-like domain, characterized by decameric repeats (DR), which comprise 14 to 16 DR tandems. Each DR is composed of 10 consensus amino acids (-A-T/M-E-A-Q-T-T-X-P/L-A/T-) and is notably rich in O-glycosylated threonines (30%) and prolines (10%). A proposed function of the DR is to elongate the protein backbone needed for selectin binding. However, the precise role of DR in PSGL-1s antiviral mechanisms has yet to be fully elucidated. In this study, we performed DR deletion mutagenesis and molecular modeling, systematically deleting from one DR to all DRs, and quantified their effects on PSGL-1s antiviral functions. Here, we demonstrate that DR is necessary for PSGL-1s antiviral activity. Deleting DR did not affect virion incorporation of PSGL-1, but diminished PSGL-1s ability to hinder virion attachment to target cells. We also discovered that individual single DR mutants retained 3.5 to 18% of the antiviral activity exhibited by full-length PSGL-1, and the basic antiviral activity of DR is cumulative; increasing the number of DRs correlates with heightened antiviral activity. Additionally, the intrinsic anti-HIV capability of DR was found to be transferrable; inserting the DR domain into the extracellular Ig-like domain of CD2 permitted the hybrid CD2-DR molecules to partially acquire the anti-HIV properties of PSGL-1. Further molecular modeling utilizing all-atom replica exchange molecular dynamics simulations highlighted a structure-function relationship between the anti-HIV potency of DR and the elongation of the DR backbone, as measured by DR backbone dihedral angles ({varphi}) and the radial distributions of peptide atom number density (rmax). These results collectively suggest that DR serves as an essential antiviral unit within the framework of PSGL-1s restriction mechanism against HIV.

immunology↗

bioRxiv2025

Modeling the Co-Activation of Inflammatory Genes1Mediated by NFκB and IRF-3 During Viral Infections

Innate immune responses of host cells are activated upon exposure to external stimuli such as viral infections. These activations trigger the signaling pathways involved in antiviral responses. Activated pathways play a crucial role in the regulation of inflammatory and antiviral responses involving transcription factors, cytokines, cell surface viral sensors, and the activation of target genes. Although the role of key transcription factors such as NF-{kappa}B and IRF-3 in the regulation of antiviral genes that encode type I interferons (IFN/{beta}) is identified and well explored. The precise mechanistic understanding that governs their complex context-dependent temporal activation remains elusive. Here, we have developed a mathematical model to demonstrate the co-regulation of the expression of the IFN{beta} gene by Nuclear Factor kappa B (NF{kappa}B) and IFN Regulatory Factor-3 (IRF-3) after their activation in host cells by the viral analogue Poly I:C. In our model, the binding activities of the transcription factors NF{kappa}B and IRF-3 at the IFN{beta} promoter are modeled using a probability-based framework. Our results demonstrate that the expression pattern of IFN{beta} postviral infections would be pertaining to the co-activation of that by NF{kappa}B and IRF-3. In addition, the immediate expression of the IFN{beta} gene and, thus, the initial host response would be mainly attributed to immediate activation of NF{kappa}B while IRF-3 would be responsible for delayed but persistent expression of the IFN{beta}. Our model provides an underlying molecular mechanism for a similar response observed for Newcastle disease virus and the Vesicular stomatitis virus infection. Furthermore, we suggest that the rapid as well as an elevated and persistent expression of IFN{beta}, would be observed later due to a temporal bias in binding of both transcription factors NF{kappa}B and IRF-3, highlighting the need for coregulation of IFN{beta} by two different signaling pathways in a sequential manner. Also, our model predicts that the binding affinity of IRF3 to the promoter region of IFN{beta} would be equal to or larger than that of NF{kappa}B for a strong and persistent antiviral responses.

systems biology↗

bioRxiv2025

Endothelial AGO1 Drives Vascular Inflammation and Atherosclerosis via a Non-Canonical Nuclear Mechanism

BACKGROUNDEndothelial cell (EC) dysfunction is a cause and consequence of vascular inflammation and lipid dysregulation in atherosclerosis, yet the molecular drivers linking EC dysfunction to systemic metabolic derangements remain incompletely understood. Moreover, whether inhibiting an endogenous gene in ECs can impact liver function, lipid profile, and the vascular inflammation in the context of atherosclerosis has not been demonstrated. We previously identified Argonaute 1 (AGO1), a component of the RNA-induced silencing complex, as a regulator of EC function in angiogenesis and obesity. However, the role of endothelial AGO1 in vascular inflammation and liver function in the context of hyperlipidemia and atherosclerosis is unknown. METHODSEC-conditional AGO1 knockout (EC-AGO1-KO) and wildtype mice were subjected to pro-atherosclerotic models induced by AAV9-PCSK9 coupled with a Western diet or partial carotid ligation. Metabolic and vascular phenotype and gene expression were analyzed. In human liver sinusoidal and aortic ECs, AGO1 was knocked down using antisense oligonucleotides (ASO), followed by assessment of inflammatory responses (qPCR, RNA-seq, ELISA, and monocyte adhesion assays). To identify the molecular mechanisms linking AGO1 and EC inflammation, Cut&Tag sequencing, chromatin immunoprecipitation, immunofluorescence, proximal ligation assay, and co-immunoprecipitation were performed. The therapeutic effect of AGO1 inhibition was assessed using ASO-delivered via lipid nanoparticle (LNP) for systemic distribution and monocyte membrane-coated nanoparticles (MoNP) to target the inflamed endothelium. RESULTSEC-AGO1-KO mice exhibited improved plasma lipid profiles, reduced hepatic steatosis, inflammation, and fibrosis, and decreased aortic atherosclerotic burden. AGO1 knockdown in ECs attenuated inflammatory responses. Mechanistically, AGO1 interacted with NF-{kappa}B p65 and promoted p65 nuclear translocation and the transcriptional activation of pro-inflammatory genes, including ICAM1 and THBS1. AGO1-ASO delivered through LNP or MoNP achieved the anti-inflammatory, anti-hyperlipidemic, and anti-atherosclerotic effects, recapitulating the phenotypes observed with EC-AGO1-KO. CONCLUSIONSEndothelial AGO1 promotes vascular inflammation and liver dysfunction in the context of hyperlipidemia and atherosclerosis, in part through a non-canonical nuclear action of AGO1 as an NF-{kappa}B coactivator. Inhibition of endothelial AGO1 provides the dual benefits of ameliorating lipid dysregulation and suppressing vascular inflammation. These results highlight EC-AGO1 as a possible therapeutic target for atherosclerosis and cardiometabolic diseases.

pathology↗

bioRxiv2025

Omics-driven Identification of Candidate Genes and SNP markers in a Major QTL Controlling Early Heading in Rice

Precise control of heading date is essential for optimizing regional adaptability, enhancing climate resilience, and maximizing grain yield in rice, making it a key breeding target. The SM93 rice line exhibits a 7-10-day earlier heading than the elite Indian variety, Samba Mahsuri (SM). F2 populations derived from a cross of SM with SM93 were phenotyped for heading date across three successive kharif (rainy) seasons (2019-2021), revealing consistent early heading and notable transgressive segregation. Initial QTL-seq analysis identified a high-confidence QTL on Chr3, qDTH3, strongly associated with days to heading (DTH). KASP assays and association mapping were subsequently performed to refine the QTL, narrowing it down to a 2.53 Mb region, explaining [~]25% of the trait. SNP markers closely linked to heading were identified. Transcriptomic analysis revealed significant differential regulation of genes within qDTH3 and upregulation of the MADS- box network in SM93 during panicle initiation, suggesting their role in promoting early heading. Our integrative strategy led to the identification of candidate genes within qDTH3, associated with heading date, phytohormone regulation, and protein turnover, include the transcription factors, OsMADS34/PAP2 (Os03g0753100), OsZHD11 (Os03g0718500), HSFA2A (Os03g0745000), OsH3 (Os03g0727200), OSH1/Oskn1 (Os03g0727000), a histidine kinase, HK4 (Os03g0717700), and a Serine carboxypeptidase, OsSCP19 (Os03g0730400). Our findings provide SNP markers in and around these genes, as potentially valuable tools for breeding early-maturing rice varieties with improved adaptability. HIGHLIGHTThis study on the SM93 rice line identifies a major QTL for early heading and describes genes and SNP markers that are closely linked to this trait, which can be used in trait advancement. By fine-tuning heading date, we can help rice varieties better withstand temperature extremes, drought, and other climate-related stresses, making it a key target for genetic improvement and breeding strategies.

plant biology↗

bioRxiv2025

A novel allele of Mitogen Activated Protein Kinase 6 is linked to disease resistance and constitutive immunity in rice.

Bacterial Blight (BB) is the most serious bacterial disease of rice. Usage of resistant cultivars has been a successful strategy in controlling BB. However, constant selection pressure causes the evolution of hypervirulent pathogenic strains that break down resistance, thus necessitating additional sources of resistance. An induced-mutant line derived from the elite rice cultivar Samba Mahsuri was identified to exhibit broad-spectrum resistance to BB. Using next-generation gene mapping approaches, we identified a genomic interval in chromosome 6 to be linked to BB resistance. Analysis of the SNPs in the locus and subsequent linkage analysis indicated that a missense SNP located in the second exon of the Mitogen-Activated Protein Kinase 6 (OsMAPK6) could be the causal mutation. A detailed examination of OsMAPK6 gene sequences in over 4000 rice genomes revealed that the mutant allele identified in this study is novel to rice germplasm. The candidate SNP causes the substitution of an invariant Serine residue with a Proline residue (S84P), thus likely affecting the protein function. Global transcriptome, metabolome, biochemical, and molecular analyses suggested that BB42 exhibit constitutive immunity. On the mechanistic front, the mutation seems to result in diminished brassinosteroid signaling in BB42. Taken together, we report a novel allele of a highly conserved MAPK gene and provide evidence for its possible association with constitutive immunity and disease resistance in rice.

plant biology↗

bioRxiv2025

CD34 serves as an intrinsic innate immune guardrail protecting stem cells from replicating retroviruses

Stem cells are highly resistant to viral infection compared to their differentiated progeny, and this resistance is associated with stem cell-specific restriction factors and intrinsic interferon stimulated genes (ISGs). In HIV infection, proviral DNA has been detected in certain bone marrow hematopoietic stem cells, yet widespread stem cell infection in vivo is restricted. Intriguingly, exposing bone marrow stem cells to HIV in vitro led to viral replication selectively only in the CD34- population, but not in the CD34+ cells. The mechanism dictating this CD34-based HIV restriction remained a mystery, especially since HIV has a capacity to antagonize restriction factors and ISGs. CD34 is a common marker of hematopoietic stem and progenitor cells. Here, we report the intrinsic antiviral properties of CD34. Expression of CD34 in HIV-1 producer cells results in the loss of progeny virion infectivity. Conversely, removal of CD34 using CRISPR/Cas9 knockout or stem cell differentiation cytokines promotes HIV-1 replication in stem cells. These results suggest that in addition to restriction factors and intrinsic ISGs, CD34 serves as a host innate protection preventing retrovirus replication in stem cells. Mechanistically, CD34 does not block viral entry, integration, and release. Instead, it becomes incorporated onto progeny virions, which inactivates virus infectivity. These findings offer new insights into innate immunity in stem cells, and highlight intriguing retrovirus-host interactions in evolution.

immunology↗

bioRxiv2025

BTK-NLRP3-Caspase1 and Gasdermin D-Caspase 11 pathways jointly drive neuroinflammation and functional impairments in a rat model of psychosocial stress

Despite serious health and economic burden, borne more prominently by lower and lower middle-income countries, pharmacotherapy for common psychiatric disorders rely on drugs altering neurotransmission, with partial efficacies. The persistence of a chronic yet sub-threshold inflammation across the periphery and the brain is well documented in the patients and animal models of these disorders and can be investigated for augmenting pharmacotherapy. IL1{beta}, a pleiotropic cytokine and a key regulator of neuroinflammation has been of particular interest in this regard. Previous studies on rodent models of anxiogenic stress show activation of a large multiprotein complex - the NLRP3 inflammasome, which increases IL1{beta} production facilitated by caspase 1, through what is considered a canonical inflammasome activation pathway. However, there exists a second non canonical inflammasome activation pathway whose impact on IL1{beta} release, inflammation and behavioral consequences remain unclear. Using rat models of physical and psychosocial stress, we observed stress-induced sex-specific upregulation of activated caspase 11 and gasdermin D N-terminal fragments, the mediators of the non-canonical inflammasome pathway that facilitates IL1{beta} release through pore formations in the plasma membrane. This is the first report of non-canonical inflammasome pathway being activated in the brain and peripheral immune cells in response to psychosocial stress. Inhibition of caspase 11 with wedelolactone, or Gasdermin D cleavage with Disulfiram reduced stress-induced elevation of IL1{beta} levels, anxiety and fear acquisition, facilitated fear extinction and recall, and improved working memory. Combination treatments targeting both canonical (ibrutinib for pBTK/NLRP3 or MCC950 for NLRP3 inhibition) and non-canonical (wedelolactone for caspase 11 or disulfiram for gasdermin D) pathways proved more efficacious in reducing stress-mediated neuroinflammation, dendritic spine elimination in the CA3 region of the hippocampus and behavioral dysfunction. Furthermore, psychosocial stress drove peripheral inflammation, in peripheral blood mononuclear cells, which was mitigated by the combination treatment. Taken together, this study reveals a novel mechanism underlying psychosocial stress involving both canonical and non-canonical inflammasome signaling to facilitate IL1{beta} induction and behavioral changes. Our finding further suggests that combined targeting of the NLRP3 inflammasome and gasdermin D could contribute to the development of future transdiagnostic therapeutic targets for stress, anxiety, and depression.

neuroscience↗

bioRxiv2025

Antioxidant role of the GABA shunt in regulating redox balance in blood progenitors during Drosophila hematopoiesis

Redox balance is crucial for normal development of stem and progenitor cells that reside in oxidative environments. This study explores the mechanisms of redox homeostasis in such niches and investigates myeloid-like blood progenitor cells that generate reactive oxygen species (ROS) and moderate it developmentally. Our findings reveal that during lymph gland development, as the blood-progenitor cells oxidize pyruvate via the TCA cycle leading to the generation of ROS, these cell also de novo synthesize GSH to counter excessive ROS and ensure redox balance. GABA metabolism, through GABA-shunt, restricts pyruvate dehydrogenase (PDH) activity and consequently TCA rate. This allows a metabolic route to sustain serine levels in these cells which is the rate limiting precursor controlling de novo GSH production. Disruption of GABA metabolism leads to a metabolic imbalance, characterized by excessive PDH activity, heightened TCA rate leading to impaired serine/GSH production and overall ROS dysregulation. Overall, the study presents a unique metabolic state whereby, in the blood-progenitor cells, by keeping PDH and TCA activity in check and promoting serine/GSH generation, GABA metabolism establishes a metabolic framework that optimises the use of ROS in blood-progenitors, while ensuring redox homeostasis.

developmental biology↗

bioRxiv2025

Diverse Defence Systems and Prophages in Human-Associated Bifidobacterium Species Reveal "Arms Race" Dynamics

Bacteria of the genus Bifidobacterium are pivotal for human health, especially in early life, where they dominate the gut microbiome in healthy infants. Bacteriophages, viruses of bacteria, are drivers of gut bacterial composition in the human gut and could affect bifidobacterial abundance. Here, we use a bioinformatics approach to explore the direct interactions occurring between human-associated Bifidobacterium spp. and prophages, as evidenced by their genomes. A total of 1,086 bifidobacterial genomes were analysed in this study, revealing complex systems to prevent viral invasion. Despite their characteristically small genomes, Bifidobacterium strains harboured more than double the number of defence systems as most bacteria. In total, 34 defence system types and 56 subtypes were detected, including several different CRISPR-Cas systems with spacers that targeted almost three-quarters of bifidobacteria-derived prophages. We identified at least one prophage which met our stringent quality control measures in [~]63% of strains, with phages exhibiting high genomic diversity and evidence of historical recombination. Additionally, prophages were found to encode various anti-defence systems, such as anti-CRISPR genes and restriction modification resistance mechanisms. In summary, our investigation reveals "arms race" dynamics drive genomic diversity in both bifidobacteria and their phages. ImportanceMembers of the Bifidobacterium genus are widely acknowledged as being highly important for human health, particularly in infants. To date, there have been a limited number of large-scale studies that have investigated the presence of prophages and anti-viral defence systems of Bifidobacterium strains from multiple human-associated species. Here, we have uncovered a complex set of anti-phage strategies encoded by Bifidobacterium strains. In addition, we have also identified a highly diverse phage mobilome present within the genomes of bifidobacteria across the genus, which also encode several unique systems for overcoming bacterial defences. Elucidating these co-evolutionary dynamics between phages and bifidobacteria may provide valuable insight into developing high-throughput methods for identifying next-generation probiotic or live biotherapeutic candidates, which may then be applied for the prevention and treatment of various diseases in humans.

microbiology↗

bioRxiv2024

PSGL-1 excludes HIV Env from virion surface through spatial hindrance involving structural folding of the decameric repeats (DR)

P-selectin glycoprotein ligand-1 (PSGL-1), a mucin-like surface glycoprotein, is primarily expressed on lymphoid and myeloid cells. PSGL-1 has recently been identified as an HIV restriction factor, blocking HIV infectivity mainly through virion incorporation that sterically hinders virion attachment to target cells. PSGL-1 also inhibits HIV Env incorporation into virions. However, the molecular mechanisms of PSGL-1-mediated Env exclusion remained unclear. Here, we investigated the role of PSGL-1s extracellular (EC) and intracellular (IC) domains in Env exclusion. We demonstrate that both EC and IC are important for Env exclusion; when EC was deleted, PSGL-1 completely lost its ability to inhibit Env incorporation, whereas when IC was deleted, PSGL-1 partially lost this activity. In addition, when the decameric repeats (DR) were deleted from EC, PSGL-1 also lost its ability to inhibit Env incorporation. Sequential DR deletion mutagenesis further demonstrated that a minimum of 9 DRs is necessary for Env exclusion. Molecular modeling of the DR structure revealed that PSGL-1 mutants with 7 or fewer DRs pose as an extended "rod-like" structure, whereas those with 9 or more DRs collapse into a "coil-like" structure that spatially excludes Env. Our studies suggest a model in which Env exclusion involves Gag-mediated PSGL-1 targeting to the virion assembly site where DR-mediated spatial exclusion blocks Env incorporation.

microbiology↗

bioRxiv2024

14-3-3 epsilon inhibits premature centriole disengagement by inhibiting the activity of Plk1 and Separase.

The 14-3-3 protein family regulates several pathways in mammalian cells, including centrosome duplication. However, the precise mechanisms by which 14-3-3 paralogs regulate the centrosome cycle remain unclear. To identify the mechanisms by which 14-3-3{varepsilon} regulates centrosome duplication, we altered two conserved acidic residues in the 14-3-3{varepsilon} phospho-peptide-binding pocket that regulate complex formation and dissociation with the associated ligands, D127 and E134, to Alanine. Altering these residues to Alanine led to opposing effects on centrosome duplication; the D127A mutant inhibited centrosome duplication, while cells expressing the E134A mutant showed the presence of supernumerary centrosomes. We demonstrate that 14-3-3{varepsilon} does not inhibit centriole duplication, as reported for 14-3-3{gamma}, but inhibits centriole disengagement. Using a combination of pharmacological and genetic approaches, we demonstrate that 14-3-3{varepsilon} inhibits the activity of Plk1 and Separase, leading to disengagement defects that ultimately lead to decreased proliferation and cell death. Our work demonstrates that different 14-3-3 paralogs regulate different steps in the centrosome cycle, and disrupting complex formation between 14-3-3{varepsilon} and Plk1 or Separase could be a novel therapeutic strategy in tumor cells.

cell biology↗

bioRxiv2024

RNA Binding of GAPDH Controls Transcript Stability and Protein Translation in Acute Myeloid Leukemia

Dysregulation of RNA binding proteins (RBPs) is a hallmark in cancerous cells. In acute myeloid leukemia (AML) RBPs are key regulators of tumor proliferation. While classical RBPs have defined RNA binding domains, RNA recognition and function in AML by non-canonical RBPs (ncRBPs) remain unclear. Given the inherent complexity of targeting AML broadly, our goal was to uncover potential ncRBP candidates critical for AML survival using a CRISPR/Cas-based screening. We identified the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a pro-proliferative factor in AML cells. Based on cross-linking and immunoprecipitation (CLIP), we are defining the global targetome, detecting novel RNA targets mainly located within 5UTRs, including GAPDH, RPL13a, and PKM. The knockdown of GAPDH unveiled genetic pathways related to ribosome biogenesis, translation initiation, and regulation. Moreover, we demonstrated a stabilizing effect through GAPDH binding to target transcripts including its own mRNA. The present findings provide new insights on the RNA functions and characteristics of GAPDH in AML.

cancer biology↗